There is an ongoing debate when it comes to prostate cancer screening, which can cause confusion and hesitation among doctors. Some believe there is not enough evidence to support screening the general population, while others suggest it is appropriate. New guidelines have been released to better help doctors decide on prostate cancer screening, and how to have an open conversation with patients about screening and treatment.

Authors of the new guidelines suggest that men over the age of 45 with a 10-year life expectancy for prostate cancer should be screened with a digital rectal exam (DRE) and a prostate-specific antigen (PSA) test. Health care providers should educate patients about the use of both tools for screening and evaluating prostate cancer risk.


Author's Bio: 

At Bel Marra we are committed to helping people lead healthier lives. We believe the one way to do this is to explore and unearth natural secrets and provide this information so that individuals can support healthy lifestyles.

By providing up-to-date health news stories, along with natural remedies and health tips, reader’s can take control of their health naturally.